Jones James bought CPIX
July 18, 2025 · Form 4 insider transaction
Jones James bought 16 shares of Cumberland Pharmaceuticals Inc. at $3.59 per share, a transaction worth $57.44. The trade was recorded as open-market purchase under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 24 days after the transaction.
Direction
Acquired (buy-side)
Shares
16
Price
$3.59
Total value
$57.44
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 18, 2025
Filing dateAugust 11, 2025
Shares owned after43,544
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.